Alpha Therapy definition of Alpha Therapy in the Free Online Encyclopedia.

Alpha Therapy

various methods of therapeutic influence on an organism, primarily by alpha particles. Several short-lived isotopes or those that separate quickly from the organism (radon, daughter products of thoron, and others) are used in alpha therapy. These isotopes produce alpha, beta, and gamma radiation; however, during therapy the organism mainly absorbs alpha particles (about 90 percent). The therapy is administered through radon baths (general and local), drinking of radon water, microsyringe, irrigations, inhalation of air enriched with radon, and so on, as well as by application to certain areas of the patient’s skin of radioactive bandages—gauze applicators with daughter products of thoron—or ointments and solutions with thorium X. Alpha therapy favorably affects the functional state of the central and autonomic nervous system, the endocrine glands, and the cardiovascular system; the therapy has a calming, pain-killing, and anti-inflammatory effect and the like. It is indicated for illnesses of the peripheral nervous system, phantom pains, neurasthenia, thyrotoxicosis (in the early stage), and other conditions. It is contraindicated for malignant tumors, tuberculosis, certain blood diseases, during pregnancy, and the like.

Alpha therapy is used at resorts with natural radon factors (water, air), like Piatigorsk, Tskhaltubo, Belokurikha, Brambach (German Democratic Republic), Gastein (Austria), and Jachymov (Czechoslovakia), as well as under nonresort conditions, in which case radon water is prepared using solutions of radium 220/86.

E. S. SHCHEPOT’EVA

Mentioned in	?		References in periodicals archive	?		Encyclopedia browser	?		Full browser	?
No references found	and Schering-Plough Corporation (NYSE: SGP) today announced they have revised their 1998 distribution agreement regarding the development, commercialization and distribution of both REMICADE(R) (infliximab), an anti-tumor necrosis factor (anti-TNF) alpha therapy for chronic inflammatory disorders, and golimumab, Centocor's next-generation, human, anti-TNF alpha therapy, which is currently in Phase 3 trials. SCHERING-PLOUGH CORPORATION - Re Agreement by PR Newswire UK Disclose and Schering-Plough Corporation (NYSE: SGP) today announced they have revised their 1998 distribution agreement regarding the development, commercialization and distribution of both REMICADE(R) (infliximab), an anti-tumor necrosis factor (anti-TNF) alpha therapy for chronic inflammatory disorders, and golimumab, Centocor's next-generation, human, anti-TNF alpha therapy, which is currently in Phase 3 trials. Centocor, Schering-Plough Revise Agreement Covering REMICADE, ... by PR Newswire Europe Horsham, PA) and Schering-Plough Corporation (Kenilworth, NJ) have revised their 1998 distribution agreement regarding the development, commercialization and distribution of both REMICADE (infliximab), an anti-tumor necrosis factor (anti-TNF) alpha therapy for chronic inflammatory disorders, and golimumab, Centocor's next-generation, human, anti-TNF alpha therapy, which is currently in Phase 3 trials. Centocor, Schering-Plough revise agreement covering REMICADE, ... by BIOTECH Patent News	alpha emission Alpha EV6 alpha fetoprotein Alpha Five alpha geek alpha globulin alpha gypsum alpha helix alpha hemolysis alpha iron alpha irradiation alpha olefin alpha particle Alpha Particles alpha position alpha ray alpha receptor alpha rhythm alpha rule Alpha Spectrometer alpha system alpha taxonomy alpha test alpha test site alpha testing Alpha Therapy alpha version alpha-adrenergic receptor alpha-particle detector alpha-particle scattering alpha-ray vacuum gage alpha/beta pruning Alphabet alphabet length alphabetic character alphabetic coding alphabetic language alphabetic string Alphaeus alphageometric technique alphameric characters alphameric typebar Alphameter alphamosaic alphamosaic technique alphanumeric alphanumeric characters alphanumeric display device alphanumeric grid alphanumeric instruction alphanumeric pager	alpha state alpha state alpha state alpha stock alpha stock Alpha Stocks Alpha Stocks alpha subunit alpha system Alpha Systems Laboratories Alpha Tau Delta Alpha Tau Omega Alpha Tauri Alpha Tauri Alpha taxonomy Alpha Team for Fun Alpha Team Headquarters Alpha Technologies Group, Inc. alpha test alpha test alpha test site alpha testing alpha tests alpha tests Alpha Thalassaemia Alpha Thalassaemia Alpha Thalassaemia Alpha Thalassemia Alpha Thalassemia Alpha Thalassemia Alpha Therapy Alpha to Omega Learning Centre Alpha tocopherol Alpha tocopherol Alpha tocopherol Alpha toxin Alpha toxin Alpha toxin Alpha toxin Alpha Track Alpha Ursae Majoris Alpha Ursae Minoris Alpha Ursae Minoris alpha version alpha version Alpha Virginis Alpha Virginis Alpha Virginis alpha w alpha w alpha w alpha w alpha w alpha wave alpha wave alpha wave Alpha Waves Alpha Waves Alpha Waves Alpha Waves Alpha Waves

Mentioned in

References in periodicals archive

Encyclopedia browser

Full browser

No references found

and Schering-Plough Corporation (NYSE: SGP) today announced they have revised their 1998 distribution agreement regarding the development, commercialization and distribution of both REMICADE(R) (infliximab), an anti-tumor necrosis factor (anti-TNF) alpha therapy for chronic inflammatory disorders, and golimumab, Centocor's next-generation, human, anti-TNF alpha therapy, which is currently in Phase 3 trials.

SCHERING-PLOUGH CORPORATION - Re Agreement by PR Newswire UK Disclose

Centocor, Schering-Plough Revise Agreement Covering REMICADE, ... by PR Newswire Europe

Horsham, PA) and Schering-Plough Corporation (Kenilworth, NJ) have revised their 1998 distribution agreement regarding the development, commercialization and distribution of both REMICADE (infliximab), an anti-tumor necrosis factor (anti-TNF) alpha therapy for chronic inflammatory disorders, and golimumab, Centocor's next-generation, human, anti-TNF alpha therapy, which is currently in Phase 3 trials.

Centocor, Schering-Plough revise agreement covering REMICADE, ... by BIOTECH Patent News